Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-04

Clinical Trial Update: A Comparison of Tolterodine and Placebo Treatments on Nocturnal Frequency and Sleep Quality in Women After Menopause. [Phase 4]

View source ↗

Summary

Phase 4 trial comparing tolterodine against placebo in postmenopausal women with urinary incontinence, assessing nocturnal frequency and sleep quality; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Detrol (tolterodine)
  • Tolterodine (tolterodine)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Urinary Incontinence | Phase 4 | Status: TERMINATED | Results posted: 2014-12-04